Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Northwest Biotherapeutics (NWBO) Preferred Shares Issued (2017 - 2024)

Northwest Biotherapeutics (NWBO) has 8 years of Preferred Shares Issued data on record, last reported at $267000.0 in Q3 2024.

  • For Q3 2024, Preferred Shares Issued fell 94.81% year-over-year to $267000.0; the TTM value through Dec 2024 reached $8.2 million, down 38.48%, while the annual FY2024 figure was $8.2 million, 38.48% down from the prior year.
  • Preferred Shares Issued reached $267000.0 in Q3 2024 per NWBO's latest filing, down from $4.3 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $7.8 million in Q4 2022 and bottomed at $267000.0 in Q3 2024.
  • Average Preferred Shares Issued over 3 years is $3.7 million, with a median of $3.5 million recorded in 2023.
  • The widest YoY moves for Preferred Shares Issued: up 81.78% in 2024, down 94.81% in 2024.
  • A 3-year view of Preferred Shares Issued shows it stood at $7.8 million in 2022, then tumbled by 55.81% to $3.4 million in 2023, then crashed by 92.22% to $267000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Preferred Shares Issued were $267000.0 in Q3 2024, $4.3 million in Q2 2024, and $3.6 million in Q1 2024.